Burden of malignancy after a primary skin cancer: Recurrence, multiple skin cancers and second primary cancers

Canadian Journal of Public Health

Volumn 101, Issue 4, 2010, Pages 123-127

  Krueger, Hans ^a,b   Williams, Dan ^a  

^a H KRUEGER AND ASSOCIATES INC   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Preventionand control; Recurrence; Second primary neoplasms; Skin neoplasms

Indexed keywords

EID: 78149268052     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03405307     Document Type: Article

References (44)

1. Krueger H, Williams D, Chomiak M, Trenaman L. The Economic Burden of Skin Cancer in Canada: Current and Projected. Canadian Partnership Against Cancer, February 2010.
2. Canadian Cancer Society's Steering Committee. Canadian Cancer Statistics 2009. Toronto, ON: Canadian Cancer Society, 2009 Available at: www.can-cer.ca/statistics (Accessed February 16 2010).
3. Hayes RC, Leonfellner S, Pilgrim W, Liu J, Keeling DN. Incidence of non-melanoma skin cancer in New Brunswick, Canada, 1992 to 2001. J Cutan Med Surg 2007;11(2):45-52.
4. Benvenuto-Andrade C, Oseitutu A, Agero AL, Marghoob AA. Cutaneous melanoma: Surveillance of patients for recurrence and new primary melanomas. Dermatol Ther 2005;18(6):423-35.
5. National Cancer Institute. Surveillance, Epidemiology and End Results. Mul-tiple Primary and Histology Coding Rules. Available at: seer.cancer.gov/ tools/mphrules/mphrules-text.pdf (Accessed February 16, 2010).
6. Krueger H, McLean D, Williams D. The Prevention of Second Primary Cancers. Basel, Switzerland: Karger, 2008.
7. Semenciw RM, Nhu DL, Marrett LD, Robson DL, Turner D, Walter SD. Methodological issues in the development of the Canadian Cancer Incidence Atlas. Stat Med 2000;19:2437-49.
8. Parkin DM, Plummer M. Comparability and quality of data. In: Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (Eds.), Cancer Incidence in Five Con-tinents. Volume VIII. Lyon, France: IARC Scientific Publications, 2002;ch. 5.
9. Ferrone CR, Porat LB, Panageas KS, Berwick M, Halpern AC, Patel A, et al. Clinicopathological features of and risk factors for multiple primary melanomas. JAMA 2005;294(13):1647-54.
10. Freedman DM, Miller BA, Tucker MA. New malignancies following melanoma of the skin, eye melanoma, and non-melanoma eye cancer. In: Curtis RE, Freedman DM, Ron E, Ries LAG, Hacker AG, Edwards BK, et al. (Eds.), New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973-2000. Bethesda, MD: National Cancer Institute, 2006;ch. 13.
11. Francken AB, Bastiaannet E, Hoekstra HJ. Follow-up in patients with localised primary cutaneous melanoma. Lancet Oncol 2005;6(8):608-21.
12. Canadian Cancer Society's Steering Committee. Canadian Cancer Statistics 2008. Toronto, ON: Canadian Cancer Society, 2008 Available at: www.can-cer.ca/statistics (Accessed February 16 2010).
13. Brisson J, Major D, Pelletier E. Evaluation of the Completeness of the Fichier des Tumeurs du Québec. Quebec, QC: Institut national de la santé publique du Québec, 2003.
14. Elder DE. Skin cancer. Melanoma and other specific nonmelanoma skin can-cers. Cancer 1995;75(1 Suppl):245-56.
15. Demers AA, Nugent Z, Mihalcioiu C, Wiseman MC, Kliewer EV. Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian popula-tion. J Am Acad Dermatol 2005;53(2):320-28.
16. Wassberg C, Thorn M, Yuen J, Ringborg U, Hakulinen T. Second primary can-cers in patients with squamous cell carcinoma of the skin: A population-based study in Sweden. Int J Cancer 1999;80(4):511-15.
17. Stang A, Ziegler S, Buchner U, Ziegler B, Jöckel KH, Ziegler V. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Ger-many: A patient-vs. diagnosis-based incidence approach. Int J Dermatol 2007;46:564-70.
18. Milan T, Pukkala E, Verkasalo PK, Kaprio J, Jansen CT, Koskenvuo M, et al. Subsequent primary cancers after basal-cell carcinoma: A nationwide study in Finland from 1953 to 1995. Int J Cancer 2000;87(2):283-88.
19. Kroumpouzos G, Konstadoulakis MM, Cabral H, Karakousis CP. Risk of basal cell and squamous cell carcinoma in persons with prior cutaneous melanoma. Dermatol Surg 2000;26(6):547-50.
20. Crocetti E, Guzzinati S, Paci E, Falcini F, Zanetti R, Vercelli M, et al. The risk of developing a second, different, cancer among 14 560 survivors of malig-nant cutaneous melanoma: A study by AIRTUM (the Italian Network of Can-cer Registries). Melanoma Res 2008;18(3):230-34.
21. Lens MB, Newton-Bishop JA. An association between cutaneous melanoma and non-Hodgkin's lymphoma: Pooled analysis of published data with a review. Ann Oncol 2005;16(3):460-65.
22. Canadian Cancer Society's Steering Committee. Table W1: Potential Years of Life Lost Due to Cancer (Web-only Content). Toronto, ON: Canadian Cancer Society 2009 Available at: www.cancer.ca/statistics (Accessed February 16 2010).
23. Friedman GD, Tekawa IS. Association of basal cell skin cancers with other cancers (United States). Cancer Causes Control 2000;11(10):891-97.
24. Frisch M, Hjalgrim H, Olsen JH, Melbye M. Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study. Ann Intern Med 1996;125(10):815-21.
25. Levi F, La Vecchia C, Te VC, Randimbison L, Erler G. Incidence of invasive cancers following basal cell skin cancer. Am J Epidemiol 1998;147(8):722-26.
26. Hemminki K, Dong C. Subsequent cancers after in situ and invasive squa-mous cell carcinoma of the skin. Arch Dermatol 2000;136(5):647-51.
27. Levi F, Randimbison L, La Vecchia C, Erler G, Te VC. Incidence of invasive cancers following squamous cell skin cancer. Am J Epidemiol 1997;146(9):734-39.
28. Cantwell MM, Murray LJ, Catney D, Donnelly D, Autier P, Boniol M, et al. Sec-ond primary cancers in patients with skin cancer: A population-based study in Northern Ireland. Br J Cancer 2009;100(1):174-77.
29. Chen J, Ruczinski I, Jorgensen TJ, Yenokyan G, Yao Y, Alani R, et al. Non-melanoma skin cancer and risk for subsequent malignancy. J Natl Cancer Inst 2008;100(17):1215-22.
30. Nugent Z, Demers AA, Wiseman MC, Mihalcioiu C, Kliewer EV. Risk of sec-ond primary cancer and death following a diagnosis of nonmelanoma skin cancer. Cancer Epidemiol Biomarkers Prev 2005;14(11 Pt 1):2584-90.
31. Venegopal B, Evans TR. Coexistent malignant melanoma and renal cell car-cinoma. Tumori 2009;95(4):518-20.
32. Krueger H, Stuart G, Gallagher R, Williams D. HPV and Other Infectious Agents in Cancer-Opportunities for Prevention and Public Health. New York, NY: Oxford University Press, 2010.
33. Forslund O, Ly H, Reid C, Higgins G. A broad spectrum of human papillo-mavirus types is present in the skin of Australian patients with non-melanoma skin cancers and solar keratosis. Br J Dermatol 2003;149(1):64-73.
34. Zur Hausen H Papillomavirus infections-a major cause of human cancers. Biochim Biophys Acta 1996. 1288(2):F55-78.
35. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classifica-tion of papillomaviruses. Virology 2004;324(1):17-27.
36. Munoz N, Castellsague X, de Gonzalez AB, Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006;24(S3):S3/1-10.
37. de Vries E, Soerjomataram I, Houterman S, Louwman MW, Coebergh JW. Decreased risk of prostate cancer after skin cancer diagnosis: A protective role of ultraviolet radiation? Am J Epidemiol2007;165(8):966-72.
38. Soerjomataram I, Louwman WJ, Lemmens VE, Coebergh JW, de Vries E. Are patients with skin cancer at lower risk of developing colorectal or breast can-cer? Am J Epidemiol2008;167(12):1421-29.
39. Tuohimaa P, Pukkala E, Scelo G, Olsen JH, Brewster DH, Hemminki K, et al. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: Vitamin D as a possible explanation. Eur J Cancer 2007;43(11):1701-12.
40. Grant WB. The effect of solar UVB doses and vitamin D production, skin can-cer action spectra, and smoking in explaining links between skin cancers and solid tumours. Eur J Cancer 2008;44(1):12-15.
41. Frisch M. Re: "Are patients with skin cancer at lower risk of developing col-orectal or breast cancer?" Am J Epidemiol 2009;169(7):918.
42. Schmid-Wendtner MH, Baumert J, Wedtner CM, Plewig G, Volkenandt M. Risk of second primary malignancies in patients with cutaneous melanoma. Br J Dermatol 2001;145(6):981-85.
43. Levi F, Randimbison L, Te VC, Conconi MM, La Vecchia C. Risk of prostate, breast and colorectal cancer after skin cancer diagnosis. Int J Cancer 2008;123(12):2899-901.
44. Youl PH, Janda M, Kimlin M. Vitamin D and sun protection: The impact of mixed public health messages in Australia. Int J Cancer 2009;124(8):1963-70.